![Debanjan Ray](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Debanjan Ray
Algemeen Directeur bij Synthekine, Inc.
Actieve functies van Debanjan Ray
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CytomX Therapeutics Holdings LLC
![]() CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | 01-08-2011 | - |
Synthekine, Inc.
![]() Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Algemeen Directeur | 01-05-2019 | - |
Normunity, Inc.
![]() Normunity, Inc. Miscellaneous Commercial ServicesCommercial Services Normunity, Inc. is a biotechnology company that creates precision immuno-oncology medicines called immune normalizers. The company is based in West Haven, CT and has subsidiaries in the United States. These medicines target novel mechanisms that free the body's normal immunity against cancer. Normunity is based on an ongoing academic-biotech partnership with the lab of Dr. Lieping Chen at Yale School of Medicine. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. The CEO of the company is Rachel W. Humphrey. | Directeur/Bestuurslid | 10-07-2023 | - |
Loopbaan van Debanjan Ray
Eerdere bekende functies van Debanjan Ray
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CYTOMX THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15-05-2017 | 15-05-2019 |
Financieel Directeur/CFO | 15-05-2017 | 15-05-2019 | |
Investor Relations Contact | 01-08-2011 | - | |
Corporate Officer/Principal | 01-08-2011 | 15-05-2017 | |
Itero Biopharmaceuticals, Inc.
![]() Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Itero Biopharmaceuticals, Inc. develops biopharmaceutical products for novel therapeutic proteins and antibodies. The firm focuses on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over marketed alternatives. It provides recombinant follicle stimulating hormone for the treatment of female infertility. The company was founded in 2006 by Dr. V. Bryan Lawlis Jr., Dr. Darlene P. Horton and Roy Jerald Beers and is headquartered in Mountain View, CA. | Corporate Officer/Principal | 01-05-2008 | 01-08-2011 |
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2006 | 01-05-2008 |
J.P. Morgan Partners LLC
![]() J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners LLC is a private equity firm founded in 1984. The firm headquartered located in New York City. | Corporate Officer/Principal | - | - |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Opleiding van Debanjan Ray
Massachusetts Institute of Technology | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Statistieken
Internationaal
Verenigde Staten | 11 |
Operationeel
Corporate Officer/Principal | 6 |
Undergraduate Degree | 1 |
Comptroller/Controller/Auditor | 1 |
Sectoraal
Health Technology | 6 |
Finance | 3 |
Commercial Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CYTOMX THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Itero Biopharmaceuticals, Inc.
![]() Itero Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Itero Biopharmaceuticals, Inc. develops biopharmaceutical products for novel therapeutic proteins and antibodies. The firm focuses on the development and commercialization of protein therapeutics that offer significant clinical and commercial advantages over marketed alternatives. It provides recombinant follicle stimulating hormone for the treatment of female infertility. The company was founded in 2006 by Dr. V. Bryan Lawlis Jr., Dr. Darlene P. Horton and Roy Jerald Beers and is headquartered in Mountain View, CA. | Health Technology |
CytomX Therapeutics Holdings LLC
![]() CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Health Technology |
Portola Pharmaceuticals LLC
![]() Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
J.P. Morgan Partners LLC
![]() J.P. Morgan Partners LLC Investment ManagersFinance J.P. Morgan Partners LLC is a private equity firm founded in 1984. The firm headquartered located in New York City. | Finance |
Synthekine, Inc.
![]() Synthekine, Inc. BiotechnologyHealth Technology Synthekine, Inc. engages as a biotechnology company. The company is headquartered in Menlo Park, CA. | Health Technology |
Normunity, Inc.
![]() Normunity, Inc. Miscellaneous Commercial ServicesCommercial Services Normunity, Inc. is a biotechnology company that creates precision immuno-oncology medicines called immune normalizers. The company is based in West Haven, CT and has subsidiaries in the United States. These medicines target novel mechanisms that free the body's normal immunity against cancer. Normunity is based on an ongoing academic-biotech partnership with the lab of Dr. Lieping Chen at Yale School of Medicine. The company is advancing an emerging pipeline of immune normalizers, including initial drug programs that target mechanisms that drive the exclusion of T-cells from immune-sensitive tumors and other mechanisms that are barriers to normal immune function in cancer. The CEO of the company is Rachel W. Humphrey. | Commercial Services |
- Beurs
- Insiders
- Debanjan Ray
- Ervaring